The Complete Wegovy vs Mounjaro Comparison for UK Patients
How To Get Wegovy vs Mounjaro: Understanding Your Treatment Options
When exploring how to get Wegovy, many patients also consider Mounjaro, creating an important decision point in your weight management journey. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors for dual hormone pathway activation. This fundamental difference means Wegovy offers the proven, focused approach of GLP-1 therapy, whilst Mounjaro provides broader hormone regulation through its dual-receptor mechanism.
EverydayMeds supplies both treatments through our GPhC-registered pharmacy (#9012878), ensuring you receive genuine, MHRA-approved medicines regardless of which option suits your needs. Our clinical team can guide you through the decision-making process, considering factors like your medical history, lifestyle requirements, and treatment goals. Both require prescription-only access through proper clinical assessment, and both must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding how to get Wegovy affordably involves comparing costs across the complete treatment pathway, where EverydayMeds offers transparent pricing for both options. Wegovy follows a five-dose escalation from 0.25mg (£79.99) through to 2.4mg maintenance (£209.99), with convenient bundle options like our Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99. Our Getting Started bundles, such as the Progress Duo (0.5mg & 1mg) at £189.99, provide seamless dose progression without multiple orders.
New customers benefit from discount code FIRST40 applied at checkout, whilst returning patients use DOSE25 to reach our competitive final prices. Both Wegovy and Mounjaro require gradual dose escalation for tolerability, making our bundle options particularly valuable for ensuring uninterrupted treatment progression. Whether choosing Wegovy's established five-dose pathway or Mounjaro's six-dose escalation to higher maintenance levels, EverydayMeds provides the complete range with next-day cold-chain delivery once prescribed.
Clinical Evidence: How To Get Wegovy With Confidence
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when used alongside diet and exercise, compared to 2.4% with placebo. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, establishing Wegovy's benefits beyond weight management alone.
When considering how to get Wegovy versus Mounjaro, both have demonstrated significant efficacy in their respective clinical programmes, though direct head-to-head comparisons aren't available due to different trial designs. The landmark STEP trials, particularly the work by Wilding et al., NEJM, 2021, established semaglutide's role in medical weight management, leading to NICE TA875 recommendation with specialist support.
How Wegovy Works: The Science Behind GLP-1 Therapy
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally released when you eat. This mechanism targets appetite centres in your brain, promoting feelings of fullness and satiety after smaller meals, whilst potentially reducing food cravings and the psychological drive to eat. The once-weekly injection delivers consistent hormone levels, providing sustained appetite regulation throughout the week. Unlike rapid-acting weight loss approaches, Wegovy works gradually by restoring natural satiety signals that may be disrupted in people with obesity. This biological approach explains why Wegovy must be combined with dietary changes and physical activity — it enhances your body's natural weight regulation rather than replacing healthy lifestyle choices.
How To Get Wegovy: Complete Ordering Process
Getting Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within standard 3 working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate for your individual circumstances. Once approved, your prescription is dispensed by our GPhC-registered pharmacy and dispatched via next-day delivery using cold-chain transport to maintain the medicine's integrity. You'll receive tracking information and storage instructions, plus ongoing support from our clinical team throughout your treatment journey. This regulated process ensures you receive genuine, MHRA-approved Wegovy whilst meeting all legal requirements for prescription-only medicine supply.
Storage and Practical Considerations for Wegovy
Wegovy requires refrigerated storage at 2-8°C until first use, but offers superior travel flexibility with 6 weeks room temperature stability below 30°C once removed from the fridge. This advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers or those with variable refrigeration access. The FlexTouch pen system provides precise dose delivery with clear visual confirmation, whilst the weekly injection schedule offers convenience compared to daily medications. Dose escalation follows a specific four-week schedule for each strength, progressing from 0.25mg starter through to 2.4mg maintenance, with each step designed to optimise tolerability whilst building therapeutic effect. Proper injection technique training is included with your first prescription, ensuring confident self-administration throughout your treatment.
Personalised Treatment Selection: How To Get Wegovy or Mounjaro
The decision between Wegovy and Mounjaro often depends on individual factors beyond their basic mechanisms, including your response to previous weight management attempts, tolerance for injection frequency, and specific medical considerations. Wegovy's five-dose escalation may suit those preferring a more gradual approach, whilst Mounjaro's higher dose range might benefit patients requiring more intensive intervention. Your prescriber will consider factors like diabetes status, cardiovascular risk, and previous medication responses when recommending between these options.
EverydayMeds' unique position as a supplier of both treatments means you can switch between options if needed, maintaining continuity of care through our clinical team. This flexibility proves valuable when individual responses vary or circumstances change, ensuring your weight management journey continues without disruption. Both treatments are available with identical service standards, delivery processes, and ongoing clinical support.
Getting Started: Your Next Steps for Wegovy or Mounjaro Access
Beginning your weight management journey with either Wegovy or Mounjaro starts with honest assessment of your goals, medical history, and lifestyle factors that influence treatment success. Complete our clinical assessment at https://everydaymeds.co.uk/collections/weight-loss, where our prescribers can evaluate both options and recommend the most suitable choice for your individual circumstances. Remember to use discount code FIRST40 for new customers or DOSE25 for returning patients at checkout to access our competitive pricing. Both treatments represent significant advances in medical weight management, offering proven pathways to sustainable weight loss when combined with appropriate lifestyle modifications. Our clinical team remains available throughout your journey, ensuring you receive optimal support whether you choose Wegovy's established GLP-1 approach or Mounjaro's dual-hormone innovation.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
